← Back to Search

Behavioural Intervention

Telemedicine for Movement Disorders

N/A
Recruiting
Research Sponsored by University of Vermont
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial will evaluate if telemedicine can be used to provide similar care to people with drug-induced movement disorders instead of in-person visits.

Who is the study for?
Adults who can consent and are willing to share clinical info with a neurology team. They must be able to travel for in-person visits or have internet access for telemedicine appointments. It's not for hospitalized patients or those needing care beyond the study's scope.Check my eligibility
What is being tested?
The trial is testing if telemedicine consultations are as effective as in-person visits for treating drug-induced movement disorders. Participants will randomly receive either type of consultation, and researchers will use the RE-AIM framework to evaluate outcomes.See study design
What are the potential side effects?
Since this trial compares two types of medical consultations rather than medications, there aren't direct side effects like you'd expect from drugs; however, technical issues or limitations in remote communication could potentially affect the quality of care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness; Client Satisfaction Questionnaire-8 (CSQ-8)
Secondary outcome measures
Effectiveness; MHC survey and Qualitative Interviews
Effectiveness; PROMIS 29+2 V2.1
Effectiveness; referral forms and visit notes
+1 more
Other outcome measures
Adoption
Implementation
Maintenance; MHC survey and qualitative interviews
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: TelemedicineExperimental Treatment1 Intervention
Group II: In-PersonExperimental Treatment1 Intervention
Control group

Find a Location

Who is running the clinical trial?

Neurocrine BiosciencesIndustry Sponsor
75 Previous Clinical Trials
6,721 Total Patients Enrolled
University of VermontLead Sponsor
272 Previous Clinical Trials
3,743,842 Total Patients Enrolled
~9 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top